Similar articles for PMID: 15280410

Year	Number of Results
1987	1
1989	1
1994	2
1995	4
1996	4
1997	4
1998	4
1999	5
2000	4
2001	4
2002	4
2003	6
2004	5
2005	12
2006	10
2007	9
2008	8
2009	6
2010	6
2011	2
2012	5
2013	6
2014	10
2015	8
2016	8
2017	6
2018	5
2019	5
2020	3
2021	3
2022	3
2023	1
2024	0

1

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma.

Messerini L, Novelli L, Comin CE. Messerini L, et al. J Clin Pathol. 2004 Aug;57(8):867-71. doi: 10.1136/jcp.2003.015784. J Clin Pathol. 2004. PMID: 15280410 Free PMC article.

2

Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma.

Mohamed A, Chenna A, Abdelfatah M, Sanjay J, Mohammad MK, Saber I, Kauh J, Elhammali B, Kaseb A. Mohamed A, et al. J Gastrointest Cancer. 2015 Jun;46(2):104-8. doi: 10.1007/s12029-015-9684-5. J Gastrointest Cancer. 2015. PMID: 25645584

3

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M. Matsuzaki Y, et al. J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. J Exp Clin Cancer Res. 1999. PMID: 10606185

4

Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.

Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ. Cheng AS, et al. Int J Oncol. 2004 Apr;24(4):853-60. Int J Oncol. 2004. PMID: 15010822

5

Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.

Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S. Koskinas J, et al. J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x. J Viral Hepat. 2005. PMID: 16255765

6

Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.

Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. Tseng PL, et al. J Surg Oncol. 2008 Oct 1;98(5):349-57. doi: 10.1002/jso.21109. J Surg Oncol. 2008. PMID: 18646041

7

SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.

Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST. Lau CP, et al. J Pathol. 2006 Dec;210(4):459-68. doi: 10.1002/path.2068. J Pathol. 2006. PMID: 17029219

8

Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome.

Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, Mori H, Arakawa Y, Kanamoto M, Iwahashi S, Miyake H. Imura S, et al. Hepatogastroenterology. 2014 Jan-Feb;61(129):129-35. Hepatogastroenterology. 2014. PMID: 24895808

9

Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.

Lee SY, Song KH, Koo I, Lee KH, Suh KS, Kim BY. Lee SY, et al. Genomics. 2012 Jun;99(6):347-54. doi: 10.1016/j.ygeno.2012.04.004. Epub 2012 Apr 29. Genomics. 2012. PMID: 22564472 Free article.

10

Angiogenic activity of hepatitis B and C viruses.

Vrancken K, Paeshuyse J, Liekens S. Vrancken K, et al. Antivir Chem Chemother. 2012 Jan 17;22(4):159-70. doi: 10.3851/IMP1987. Antivir Chem Chemother. 2012. PMID: 22182803 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

153 results

Results by year